You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
|
|---|---|
| Published in |
Journal for Immunotherapy of Cancer, December 2018
|
| DOI | 10.1186/s40425-018-0463-2 |
| Pubmed ID | |
| Authors |
Fatima Karzai, David VanderWeele, Ravi A. Madan, Helen Owens, Lisa M. Cordes, Amy Hankin, Anna Couvillon, Erin Nichols, Marijo Bilusic, Michael L. Beshiri, Kathleen Kelly, Venkatesh Krishnasamy, Sunmin Lee, Min-Jung Lee, Akira Yuno, Jane B. Trepel, Maria J. Merino, Ryan Dittamore, Jennifer Marté, Renee N. Donahue, Jeffrey Schlom, Keith J. Killian, Paul S. Meltzer, Seth M. Steinberg, James L. Gulley, Jung-Min Lee, William L. Dahut |
X Demographics
The data shown below were collected from the profiles of 77 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 45 | 58% |
| Spain | 4 | 5% |
| Japan | 3 | 4% |
| Singapore | 2 | 3% |
| India | 2 | 3% |
| Turkey | 2 | 3% |
| United Kingdom | 2 | 3% |
| Switzerland | 1 | 1% |
| Netherlands | 1 | 1% |
| Other | 5 | 6% |
| Unknown | 10 | 13% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 37 | 48% |
| Scientists | 20 | 26% |
| Practitioners (doctors, other healthcare professionals) | 15 | 19% |
| Science communicators (journalists, bloggers, editors) | 4 | 5% |
| Unknown | 1 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 106 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 106 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 18 | 17% |
| Student > Ph. D. Student | 12 | 11% |
| Other | 11 | 10% |
| Student > Master | 11 | 10% |
| Student > Bachelor | 8 | 8% |
| Other | 17 | 16% |
| Unknown | 29 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 35 | 33% |
| Biochemistry, Genetics and Molecular Biology | 13 | 12% |
| Agricultural and Biological Sciences | 6 | 6% |
| Computer Science | 3 | 3% |
| Nursing and Health Professions | 3 | 3% |
| Other | 9 | 8% |
| Unknown | 37 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 54. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 June 2022.
All research outputs
#788,529
of 25,559,053 outputs
Outputs from Journal for Immunotherapy of Cancer
#191
of 3,459 outputs
Outputs of similar age
#17,651
of 446,760 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#2
of 63 outputs
Altmetric has tracked 25,559,053 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,459 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.7. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,760 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 63 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.